白血球分离术市场规模、份额和成长分析（按类型、应用、最终用户和地区划分）—2026-2033年产业预测

预计到 2024 年，白血球分离术市场规模将达到 847.1 亿美元，到 2025 年将达到 922.5 亿美元，到 2033 年将达到 1824.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 8.9%。

白血球分离术市场是医疗保健领域至关重要且充满活力的细分市场，为多种疾病提供重要的治疗和诊断解决方案。该过程包括从血液中选择性地提取白血球，从而促进白血病、淋巴瘤、自体免疫疾病等疾病的治疗和研究。市场成长的主要驱动力是血液疾病发病率的上升以及提高手术疗效和安全性的技术创新。然而，医疗专业人员认知不足和高成本等挑战可能会阻碍其广泛应用。显着的发展趋势包括个人化医疗方法以及与其他疗法的整合，而机会则在于免疫疗法研究的拓展、精准医疗以及医疗基础设施的改善，尤其是在发展中地区。

白血球分离术市场驱动因素

血液疾病（包括白血病和淋巴瘤）的日益普遍是白血球分离术市场的主要驱动力。对有效治疗方法这些疾病的需求促使白血球分离术的使用量增加，而白血球分离术对于控制白血球增多症至关重要。尤其是在急性白血病病例中，该疗法可以迅速减少血液中的白血病细胞数量，这对于缓解患者症状和后续治疗性介入至关重要。随着越来越多的患者被诊断出患有这些疾病，对白血球分离术的需求持续增长，凸显了其在患者照护中的关键作用。

限制白血球分离术市场的因素

由于医护人员和患者对白血球分离术的益处认知度较低，该疗法市场面临严峻挑战。这种认知不足可能会阻碍市场扩张，并凸显了进行全面教育和宣传活动以推广白血球分离术作为有效治疗方案的必要性。此外，白血球分离术设备及其耗材的经济负担也构成了一项进入障碍，尤其是在资源匮乏的地区。雪上加霜的是，这些操作需要技术娴熟的医护人员来执行，这可能会限制白血球分离术在临床环境中的广泛应用。

白血球纯化疗法市场趋势

白血球分离术市场的一个显着趋势是其与先进细胞疗法（尤其是嵌合体抗原受体 (CAR) T 细胞疗法）的融合。这种协同作用透过利用白血球分离术高效采集患者来源的白血球进行基因改造，增强了癌症治疗的疗效。随着个人化医疗需求的日益增长，白血球分离术正成为最先进治疗通讯协定的重要组成部分，有助于制定旨在改善患者预后的个人化治疗策略。这种日益增强的相互依存关係正在推动白血球分离术市场的创新、投资和扩张，反映了肿瘤学实践的变革性变化。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步
• 监管环境
• 案例研究

全球白血球分离术市场规模（按类型及复合年增长率划分）（2026-2033 年）

• 一次性
• 装置
  • 离心分离器
  • 膜分离设备

全球白血球分离术市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

• 研究用途
• 治疗用途

全球白血球分离术市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 血液成分供应商和血站
• 学术和研究机构
• 製药和生物技术公司
• 医院及输血中心

全球白血球分离术市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Terumo BCT
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• Asahi Kasei Corporation
• Macopharma SA
• Miltenyi Biotec
• Medica Spa
• Puriblood Medical Co. Ltd.
• Beijing ZKSK Technology Co. Ltd.
• SB-Kawasumi Laboratories, Inc.
• Nikkiso Co., Ltd.
• Charles River Laboratories International, Inc.
• Discovery Life Sciences, Inc.
• Precision for Medicine, Inc.
• StemExpress, LLC
• Lonza Group AG
• Caltag Medsystems Limited
• Stemcell Technologies
• Trina Bioreactives AG
• AcceGen
• First Choice Bio LLC

结论与建议

Leukapheresis Market size was valued at USD 84.71 Billion in 2024 and is poised to grow from USD 92.25 Billion in 2025 to USD 182.47 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

The leukapheresis market represents a crucial and dynamic segment in the medical realm, offering essential therapeutic and diagnostic solutions for a range of diseases. This process involves the selective extraction of white blood cells from the bloodstream, fostering advancements in treatment and research for conditions like leukemia, lymphoma, and autoimmune disorders. The market's growth is primarily propelled by the rising incidence of hematologic disorders and technological innovations that enhance the procedure's efficacy and safety. However, challenges such as limited awareness among healthcare providers and high costs may impede access. Notable trends include personalized medicine approaches and integration with other therapies, while opportunities lie in expanding immunotherapy research, precision medicine, and improved healthcare infrastructure, particularly in developing regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Leukapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Leukapheresis Market Segments Analysis

Global Leukapheresis Market is segmented by Type, Application, End User, and region. Based on Type, the market is segmented into Disposables, Devices. Based on Application, the market is segmented into Research Applications, Therapeutic Applications. Based on End User, the market is segmented into Blood component providers & blood centers, Academic & research institutes, Pharmaceutical & biotechnology companies, Hospitals & transfusion centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Leukapheresis Market

The growing prevalence of hematologic disorders, including leukemia and lymphoma, significantly propels the leukapheresis market. The need for effective treatment options to address these conditions has led to an increased utilization of leukapheresis, which is essential for managing elevated white blood cell counts. This procedure is particularly important in acute leukemia cases, where it can swiftly lower the number of leukemic cells in the bloodstream, thereby alleviating patient symptoms and facilitating the administration of subsequent therapeutic interventions. As more individuals are diagnosed with these disorders, the demand for leukapheresis continues to expand, underscoring its vital role in patient care.

Restraints in the Leukapheresis Market

The leukapheresis market faces significant challenges due to limited awareness among both healthcare providers and patients regarding the advantages of leukapheresis procedures. This lack of understanding can impede market expansion, highlighting the need for comprehensive education and awareness initiatives to promote leukapheresis as a viable treatment option. Additionally, the financial burden associated with leukapheresis devices and their consumables poses a barrier to accessibility, especially in areas with constrained resources. Furthermore, the requirement for skilled healthcare professionals to administer these procedures further complicates matters, potentially limiting the broader adoption of leukapheresis in clinical practice.

Market Trends of the Leukapheresis Market

The leukapheresis market is experiencing a notable trend towards its integration with advanced cell-based therapies, particularly chimeric antigen receptor (CAR) T-cell therapy. This synergy enhances the effectiveness of cancer treatments by utilizing leukapheresis for the efficient collection of patient-derived white blood cells necessary for genetic modifications. As the demand for personalized medicine escalates, leukapheresis is becoming an essential component of cutting-edge therapeutic protocols, enabling the development of tailored treatment strategies that aim to improve patient outcomes. This growing interdependence is driving innovation, investment, and expansion within the leukapheresis market, reflecting a transformative shift in oncology practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Leukapheresis Market Size by Type & CAGR (2026-2033)

• Market Overview
• Disposables
• Devices
  • Centrifugal Devices
  • Membrane Separators

Global Leukapheresis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Research Applications
• Therapeutic Applications

Global Leukapheresis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Blood component providers & blood centers
• Academic & research institutes
• Pharmaceutical & biotechnology companies
• Hospitals & transfusion centers

Global Leukapheresis Market Size & CAGR (2026-2033)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Terumo BCT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica Spa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Puriblood Medical Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing ZKSK Technology Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SB-Kawasumi Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Discovery Life Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision for Medicine, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemExpress, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caltag Medsystems Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trina Bioreactives AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AcceGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• First Choice Bio LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation